CDMO
CDMO
Custom development and manufacturing across modalities.
Peptides
High-quality peptide development, from concept to scale.
Fermentation
Full Scale Fermentation Development
Featured Event
June 16, 2026
Shanghai, China

CPHI China 2026

Event Details
About Us
Careers
Featured Event
June 16, 2026
Shanghai, China

CPHI China 2026

Event Details
Knowledge Hub
Knowledge Center
Insights and stories from TAPI.
Events
Where to find us next around the globe.
Site Inspections
Recent inspections and regulatory visits.
Regulatory updates
Latest changes to our portfolio.
Video Hub
Deep Expertise Through Video Stories.
Featured Event
June 16, 2026
Shanghai, China

CPHI China 2026

Event Details
Recommended:
Articles
Industry updates
R&D
API
TAPI Connect
TAPI Connect
CPHI China 2026

CPHI China 2026

Event Details
EHS ESG R&D
June 29, 2026
6-minute read

Advancing Sustainable Science

Sustainability in the pharmaceutical industry is not only about setting ambitious goals. It is about embedding responsible practices into the everyday environments where science happens. At TAPI, this includes the laboratories where our teams develop, improve, and support complex API and CDMO solutions. As part of our commitment to responsible innovation and continuous improvement, TAPI […]

Read More
Filter by:
Articles CDMO R&D
May 19, 2026
4-minute read

Scalable Synthesis of Cantharidin: a new TAPI R&D publication highlighting DoE-driven process and crystallization excellence 
Read More
Articles EHS ESG Industry updates R&D
April 13, 2026
7-minute read

TAPI EHS&S Awards 2025: Celebrating the People Driving Safer, Smarter, More Sustainable Progress
Read More
Articles CDMO Industry updates
March 23, 2026
2-minute read

Joint Interview: TAPI and Antheia on Partnership, Progress, and the Future of Pharma
Read More
Press Release Industry updates
December 17, 2025
2-minute read

TAPI and Sagimet Biosciences Announce Global License Agreement for Innovative Forms of Resmetirom API for Sagimet’s Fixed Dose Combination Program
Read More
Articles CDMO
December 17, 2025
4-minute read

Accelerating Peptide Innovation Through Science, Agility, and Collaboration 
Read More
Press Release CDMO
November 20, 2025
2-minute read

TAPI and Antheia Announce Strategic Partnership to Advance Commercialization of Biosynthetic Pharmaceutical Ingredients
Read More
Articles CDMO EHS Manufacturing
November 9, 2025
4-minute read

Transforming GLP-1 Manufacturing with PAT-Generated Data: A Smarter, Greener Approach 
Read More
Articles EHS ESG Manufacturing
September 29, 2025
3-minute read

Sustainable by Design: How TAPI is Building a Greener Future in API Manufacturing 
Read More
Articles R&D
August 25, 2025
3-minute read

How Innovative Computational Tools and Automation Are Reshaping Solid Form Development 
Read More

Last Site Inspections

Feb 8, 2025

Teva API had a successful inspection in the Teva api Mexico site by Local MOH

Jan 15, 2025

Teva API had a successful inspection in the Teva api India, Gajraula site by Local MOH

Jan 4, 2025

Teva API had a successful inspection in the Teva api Croatia, Zagred site by Local MOH

View All

Latest Catalog Updates

2026
Fidaxomicin
US DMF
2026
Fidaxomicin
EU DMF
2026
Mavacamten
US DMF
2026
Zavegepant
US DMF
View All

Contact us

Step 1 of

    First name*
    Last name*
    Business email*
    Company*
    Job title*
    Country*
    I'm interested in*
    Segment of interest*
    Tell us more about your project
    Select product*
    Formulation
    Project type*
    Target market
    Quantity
    Comments
    Disclaimer: This material might be protected by exclusive rights such as patents and/or supplementary protection certificates or extensions in certain jurisdictions, and therefore might not be available for specific countries. TAPI will only be able to offer and supply this pharmaceutical ingredient in the countries and exclusively for uses that are exempt from infringement of such exclusive rights in accordance with applicable law. TAPI requires adequate confirmation of the exempt use upon ordering.
    By clicking submit, you are agreeing to our Privacy Policy